Philip E. Binzel, Jr., M.D.
[back] Doctors   [back] Laetrile

ALIVE AND WELL by Philip E. Binzel, Jr., M.D.

Laetrile and the Life Saving Substance Called Cyanide by Philip Binzel, Jr., M.D.

Philip E. Binzel, a native of Bowling Green, Kentucky, has been practicing medicine for over forty years. He is a graduate of the Medical School at St. Louis University in Missouri and did his internship at Christ Hospital in Cincinnati, Ohio. In 1955 he entered Family Practice in Washington Court House, Ohio, where he currently resides.

In 1974 he began to investigate the role of nutrition in human disorders and came to the conclusion that this was an important field of knowledge. Cautiously, he began to incorporate that knowledge into his medical practice and, based on personal experience, developed a highly effective protocol for the treatment of a wide range of disorders, including cancer.

This led him into conflict with mainstream medicine which continues to remain oriented toward drugs, surgery, and radiation. He has been forced to fight for the right to practice medicine in accordance with his conscience. He has chosen to do what he feels is best for his patients, regardless of pressure to conform to the narrow limits prescribed by orthodoxy.

Dr. Binzel is now officially retired but occasionally consults with patients and their physicians, usually without charging a fee for his service.

In 1994, P.E. Binzel published his results from treating cancer patients with Laetrile between 1974 and 1991. He used a combination of intravenous and oral Laetrile. Intravenous doses started with 3 gms and worked up to 9 gms. After a period of months, oral Laetrile, 1 gm at bedtime, was begun in place of the injections. Binzel also used various nutrient supplements and pancreatic enzymes, as well as a low animal-protein, no junk-food diet as part of his regimen. Out of a series of 180 patients with primary cancer (non-metastasized, confined to a single organ or tissue), 138 were still alive in 1991 when he compiled his treatment results. At that time, 58 of the patients had been followed for 2 to 4 years, while 80 had a medical follow-up from 5 to 18 years. Of the 42 patients who had died by 1991, 23 died from their cancers, 12 from unrelated causes, and 7 died of "cause unknown".

Among his metastatic cancer patients, 32 of 108 died from their disease, while 6 died of unrelated causes, and 9 died of "cause unknown". Of his 61 patients still alive in 1991, 30 had a follow-up between 2 and 4 years, while 31 had been followed for 5 to 18 years.

Binzel's results are impressive. Some of the individual patients discussed in his book were still alive (and well!) 15-18 years after their initial Laetrile treatment. Binzel also notes that none of the cancer diagnoses were made by him (a small town, "family doctor") - all patients had diagnoses from other physicians. Many had already suffered the ravages of standard "cut-bum-and poison" (surgery/X-ray/chemotherapy) medicine before being given up as hopeless cases by orthodox doctors.